Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Csrnp3 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CSRNP3 mRNA | CTD | PMID:29097150 | Csrnp3 | Rat | 17beta-estradiol | increases expression | ISO | Csrnp3 (Mus musculus) | 6480464 | Estradiol results in increased expression of CSRNP3 mRNA | CTD | PMID:25210133 | Csrnp3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Csrnp3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSRNP3 mRNA | CTD | PMID:24058054 | Csrnp3 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CSRNP3 mRNA | CTD | PMID:32109520 | Csrnp3 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | 2,2',4,4',5-brominated diphenyl ether results in decreased expression of CSRNP3 mRNA | CTD | PMID:26705709 | Csrnp3 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CSRNP3 mRNA; Propylthiouracil results in decreased expression of H3C7 more ... | CTD | PMID:24780913|PMID:30047161 | Csrnp3 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of CSRNP3 mRNA | CTD | PMID:31881176 | Csrnp3 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CSRNP3 mRNA | CTD | PMID:33354967 | Csrnp3 | Rat | all-trans-retinoic acid | increases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CSRNP3 mRNA | CTD | PMID:23724009 | Csrnp3 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of CSRNP3 mRNA | CTD | PMID:30047161 | Csrnp3 | Rat | antirheumatic drug | increases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of CSRNP3 mRNA | CTD | PMID:24449571 | Csrnp3 | Rat | aristolochic acid A | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CSRNP3 mRNA | CTD | PMID:33212167 | Csrnp3 | Rat | arsenite(3-) | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CSRNP3 mRNA] | CTD | PMID:32406909 | Csrnp3 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of CSRNP3 gene | CTD | PMID:28931070 | Csrnp3 | Rat | benzo[a]pyrene | affects methylation | ISO | CSRNP3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CSRNP3 promoter | CTD | PMID:27901495 | Csrnp3 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CSRNP3 mRNA | CTD | PMID:25181051 | Csrnp3 | Rat | bisphenol A | decreases expression | ISO | Csrnp3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CSRNP3 mRNA | CTD | PMID:32156529 | Csrnp3 | Rat | bisphenol A | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CSRNP3 gene | CTD | PMID:31601247 | Csrnp3 | Rat | bisphenol A | increases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of CSRNP3 mRNA | CTD | PMID:29275510 | Csrnp3 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CSRNP3 gene | CTD | PMID:28505145 | Csrnp3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CSRNP3 mRNA | CTD | PMID:29097150|PMID:30816183|PMID:32528016 | Csrnp3 | Rat | bisphenol F | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of CSRNP3 gene | CTD | PMID:31601247 | Csrnp3 | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of H3C7 mRNA | CTD | PMID:24386269 | Csrnp3 | Rat | copper atom | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CSRNP3 mRNA | CTD | PMID:20971185 | Csrnp3 | Rat | copper(0) | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CSRNP3 mRNA | CTD | PMID:20971185 | Csrnp3 | Rat | cyclosporin A | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CSRNP3 mRNA | CTD | PMID:20106945 | Csrnp3 | Rat | DDT | increases methylation | EXP | | 6480464 | DDT results in increased methylation of CSRNP3 gene | CTD | PMID:30207508 | Csrnp3 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CSRNP3 mRNA | CTD | PMID:21266533 | Csrnp3 | Rat | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of CSRNP3 mRNA | CTD | PMID:30723492 | Csrnp3 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of H3C7 mRNA | CTD | PMID:25152437 | Csrnp3 | Rat | dorsomorphin | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Csrnp3 | Rat | doxorubicin | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CSRNP3 mRNA | CTD | PMID:29803840 | Csrnp3 | Rat | entinostat | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Csrnp3 | Rat | entinostat | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | entinostat results in decreased expression of CSRNP3 mRNA | CTD | PMID:26272509 | Csrnp3 | Rat | ethanol | affects splicing | ISO | Csrnp3 (Mus musculus) | 6480464 | Ethanol affects the splicing of CSRNP3 mRNA | CTD | PMID:30319688 | Csrnp3 | Rat | folic acid | decreases expression | ISO | Csrnp3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CSRNP3 mRNA | CTD | PMID:25629700 | Csrnp3 | Rat | fulvestrant | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CSRNP3 gene; [bisphenol F co-treated more ... | CTD | PMID:31601247 | Csrnp3 | Rat | fulvestrant | increases methylation | ISO | CSRNP3 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of CSRNP3 gene | CTD | PMID:31601247 | Csrnp3 | Rat | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of CSRNP3 mRNA | CTD | PMID:26194646 | Csrnp3 | Rat | hydroquinone | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of CSRNP3 mRNA | CTD | PMID:31256213 | Csrnp3 | Rat | lead(0) | affects expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Lead affects the expression of CSRNP3 mRNA | CTD | PMID:28903495 | Csrnp3 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of CSRNP3 mRNA | CTD | PMID:30047161 | Csrnp3 | Rat | methylmercury chloride | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CSRNP3 mRNA | CTD | PMID:26272509|PMID:28001369 | Csrnp3 | Rat | methylmercury chloride | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Csrnp3 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of CSRNP3 mRNA | CTD | PMID:24810058 | Csrnp3 | Rat | nickel atom | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of CSRNP3 mRNA | CTD | PMID:25583101 | Csrnp3 | Rat | okadaic acid | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of CSRNP3 mRNA | CTD | PMID:38832940 | Csrnp3 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [Oxaliplatin co-treated with Topotecan] results in increased expression of H3C7 mRNA | CTD | PMID:25729387 | Csrnp3 | Rat | panobinostat | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Csrnp3 | Rat | paracetamol | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CSRNP3 mRNA | CTD | PMID:29067470 | Csrnp3 | Rat | pirinixic acid | multiple interactions | ISO | Csrnp3 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Csrnp3 | Rat | SB 431542 | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Csrnp3 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of CSRNP3 mRNA | CTD | PMID:19281266 | Csrnp3 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of CSRNP3 mRNA | CTD | PMID:30047161 | Csrnp3 | Rat | sunitinib | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CSRNP3 mRNA | CTD | PMID:31533062 | Csrnp3 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [Oxaliplatin co-treated with Topotecan] results in increased expression of H3C7 mRNA | CTD | PMID:25729387 | Csrnp3 | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of H3C7 mRNA | CTD | PMID:25729387 | Csrnp3 | Rat | torcetrapib | increases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of CSRNP3 mRNA | CTD | PMID:23228038 | Csrnp3 | Rat | trichostatin A | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CSRNP3 mRNA | CTD | PMID:26272509 | Csrnp3 | Rat | trichostatin A | multiple interactions | ISO | CSRNP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Csrnp3 | Rat | triptonide | increases expression | ISO | Csrnp3 (Mus musculus) | 6480464 | triptonide results in increased expression of CSRNP3 mRNA | CTD | PMID:33045310 | Csrnp3 | Rat | valproic acid | decreases methylation | ISO | CSRNP3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of CSRNP3 gene | CTD | PMID:29154799 | Csrnp3 | Rat | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of CSRNP3 mRNA | CTD | PMID:29427782 | Csrnp3 | Rat | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CSRNP3 mRNA | CTD | PMID:29427782 | Csrnp3 | Rat | valproic acid | decreases expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CSRNP3 mRNA | CTD | PMID:23179753|PMID:28001369 | Csrnp3 | Rat | valproic acid | affects expression | ISO | CSRNP3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CSRNP3 mRNA | CTD | PMID:25979313 | Csrnp3 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of CSRNP3 mRNA | CTD | PMID:19015723 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















